| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |